<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1728-8800-2013-4-36-40</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-211</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МЕТАБОЛИЧЕСКИЙ СИНДРОМ И САХАРНЫЙ ДИАБЕТ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>METABOLIC SYNDROME AND DIABETES MELLITUS</subject></subj-group></article-categories><title-group><article-title>ВЫЯВЛЕНИЕ САХАРНОГО ДИАБЕТА В ПОПУЛЯЦИИ ПОЖИЛОГО НАСЕЛЕНИЯ КРУПНОГО РОССИЙСКОГО ГОРОДА</article-title><trans-title-group xml:lang="en"><trans-title>DETECTION OF DIABETES MELLITUS IN THE OLDER POPULATION OF A LARGE RUSSIAN CITY</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шальнова</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shalnova</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>руководитель отдела эпидемиологии ХНИЗ</p><p>Тел.: 8 (903) 238-87-83 </p></bio><bio xml:lang="en"><p>tel.: 8 (903) 238-87-83</p></bio><email xlink:type="simple">sshalnova@gnicpm.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смирнов</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Smirnov</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>м.н.с. отдела</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Деев</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Deev</surname><given-names>A. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>руководитель лаборатории биостатистики</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Баланова</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Balanova</surname><given-names>Yu. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>с. н.с. отдела эпидемиологии ХНИЗ</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Константинов</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Konstantinov</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>в. н.с. отдела</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Капустина</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kapustina</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>с. н.с. отдела</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Киселева</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kiseleva</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>в. н.с. отдела</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Школьникова</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shkolnikova</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>рук. </p></bio><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ “Государственный научно-исследовательский центр профилактической медицины” Минздрава России</institution></aff><aff xml:lang="en"><institution>State Research Centre for Preventive Medicine</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ “Государственный научно-исследовательский центр профилактической медицины” Минздрава России; &#13;
ГБОУ “Первый Московский государственный медицинский университет им. И. М. Сеченова” Минздрава России</institution></aff><aff xml:lang="en"><institution>State Research Centre for Preventive Medicine; &#13;
I.M. Sechenov First Moscow State University</institution></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБУ “Научно-исследовательский центр педиатрии и детской хирургии” Минздрава России, Москва; &#13;
Федеральный детский центр диагностики и лечения нарушений ритма сердца; &#13;
Max-Planck Institute for demographic Research. Rostock</institution></aff><aff xml:lang="en"><institution>Research Centre of Pediatrics and Surgery, Moscow;  &#13;
Max Planck Institute for Demographic Research, Rostock, Germany</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>20</day><month>08</month><year>2013</year></pub-date><volume>12</volume><issue>4</issue><fpage>36</fpage><lpage>40</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шальнова С.А., Смирнов Д.А., Деев А.Д., Баланова Ю.А., Константинов В.В., Капустина А.В., Киселева Н.В., Школьникова М.А., 2013</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="ru">Шальнова С.А., Смирнов Д.А., Деев А.Д., Баланова Ю.А., Константинов В.В., Капустина А.В., Киселева Н.В., Школьникова М.А.</copyright-holder><copyright-holder xml:lang="en">Shalnova S.A., Smirnov D.A., Deev A.D., Balanova Y.A., Konstantinov V.V., Kapustina A.V., Kiseleva N.V., Shkolnikova M.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/211">https://cardiovascular.elpub.ru/jour/article/view/211</self-uri><abstract><p>Одной из важнейших проблем современной медицины является “эпидемия” сахарного диабета (СД). С постарением населения, увеличением продолжительности жизни и улучшением качества лечения решение этой проблемы становится одной из первостепенных целей здравоохранения.</p><sec><title>Цель</title><p>Цель. Оценить долю участия различных критериев в выявлении СД в популяционном исследовании у лиц ≥55 лет, проживающих в условиях мегаполиса.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В работе использована одномоментная представительная выборка мужчин и женщин в рамках исследования “Стресс, старение и здоровье в России”. Всего обследованы 1868 человек обоего пола, в т. ч. 893 мужчины. Отклик составил 64%. Всем пациентам проводили стандартный опрос, включающий социально-демографические характеристики, определение факторов риска (ФР), сбор анамнеза заболеваний, лабораторных данных. Определяли уровень глюкозы натощак и гликированный гемоглобин (HbA1c). Диагноз СД подтверждался наличием хотя бы одного из 3 критериев: 1. положительный ответ на вопрос: “Говорил ли Вам врач, что у Вас СД?”, 2. уровень глюкозы натощак ≥7,0 ммоль/л, 3. уровень HbA1c ≥6,5%. Статистическая обработка результатов осуществлялась с помощью пакета статистических программ SPSS 16.0 и SAS (версия 6.12).</p></sec><sec><title>Результаты</title><p>Результаты. С помощью опроса СД в анамнезе был выявлен у 11,3% обследуемых, в т. ч. среди мужчин 10,3%, среди женщин – 12,2%. Частота выявления HbA1c ≥6,5% составила 16,6%, 16,1%, 17,0%, соответственно. Гипергликемия (ГГ) при уровне глюкозы ≥7,0 ммоль/л была обнаружена у 13,3% в целом по выборке: 15,3% и 11,5% у мужчин и женщин, соответственно. Таким образом, распространенность СД при использовании трех критериев диагностики составила 25,3%, среди мужчин 24,9%, среди женщин – 25,6%, из которых более половины не знали о наличии у них заболевания. Статистически значимых различий по полу, возрасту и образованию между изучаемыми показателями не обнаружено.</p></sec><sec><title>Заключение</title><p>Заключение. Необходимо усилить возможности служб здравоохранения по информированности населения о последствиях СД с целью своевременной диагностики СД среди населения, особенно среднего и пожилого возрастов. </p></sec></abstract><trans-abstract xml:lang="en"><p>One of the major problems of modern medicine is the epidemics of diabetes mellitus (DM). Population ageing, increased life expectancy, and improved treatment quality make this problem one of the key healthcare targets.</p><sec><title>Aim</title><p>Aim. To assess the diagnostic value of different criteria in the DM detection among megapolis-dwelling participants of a population study, aged 55 years and older.</p></sec><sec><title>Material and methods</title><p>Material and methods. The cross-sectional data came from a representative sample of SAHR (Survey on Stress, Aging, and Health in Russia) study (n=1868, including 893 men; response rate 64%). All participants underwent a standard questionnaire survey on sociodemographic characteristics, risk factors (RFs), and medical history, as well as a clinical and laboratory examination, with the measurement of fasting glucose and glycated haemoglobin (HbA1c). DM was diagnosed if at least one of following criteria was met: 1) positive response to the question “Has a doctor ever told you that you have diabetes?”; 2) fasting glucose ≥7,0 mmol/l; and 3) HbA1c ≥6,5%. Statistical analyses were performed in SPSS (version 16.0) and SAS (version 6.12).</p></sec><sec><title>Results</title><p>Results. Anamnestic evidence of DM was obtained in 11,3% of the participants (10,3% of men and 12,2% of women). Levels of HbA1c ≥6,5% were registered in 16,6% (16,1% of men and 17,0% of women). Hyperglycemia (fasting glucose ≥7,0 mmol/l) was observed in 13,3% (15,3% of men and 11,5% of women). The prevalence of DM, according to all three diagnostic criteria, reached 25,3% (24,9% in men and 25,6% in women). More than a half of DM patients were not aware of their diabetes. There were no statistically significant differences in the assessed parameters by gender, age, or education.</p></sec><sec><title>Conclusion</title><p>Conclusion. It is important to strengthen the potential of healthcare services in terms of increasing population awareness of DM and its consequences and facilitating early DM diagnostics, particularly in middle-aged and elderly people. </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>сахарный диабет</kwd><kwd>критерии диагностики</kwd><kwd>распространенность</kwd><kwd>возраст ≥55 лет</kwd></kwd-group><kwd-group xml:lang="en"><kwd>diabetes mellitus</kwd><kwd>diagnostic criteria</kwd><kwd>prevalence</kwd><kwd>age ≥55 years</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011; 378 (9785): 31–40.</mixed-citation><mixed-citation xml:lang="en">Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011; 378 (9785): 31–40.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87 (1): 4–14.</mixed-citation><mixed-citation xml:lang="en">Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87 (1): 4–14.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">International Diabetes Federation (2011). Diabetes atlas, fifth edition: www.diabetesatlas.org</mixed-citation><mixed-citation xml:lang="en">International Diabetes Federation (2011). Diabetes atlas, fifth edition: www.diabetesatlas.org</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Global health risks. Mortality and burden of disease attributable to selected major risks. Geneva, World Health Organization, 2009.</mixed-citation><mixed-citation xml:lang="en">Global health risks. Mortality and burden of disease attributable to selected major risks. Geneva, World Health Organization, 2009.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Diabetes in the UK. 2012. Key statistics on diabetes. April 2012.</mixed-citation><mixed-citation xml:lang="en">Diabetes in the UK. 2012. Key statistics on diabetes. April 2012.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Dunstan D, Zimmet PZ, Welborn T, et al. on behalf of the AusDiab Steering Committee. The Rising Prevalence of Diabetes and Impaired Glucose Tolerance. The Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25:829–34.</mixed-citation><mixed-citation xml:lang="en">Dunstan D, Zimmet PZ, Welborn T, et al. on behalf of the AusDiab Steering Committee. The Rising Prevalence of Diabetes and Impaired Glucose Tolerance. The Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25:829–34.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Soriguer F, Goday A, Bosch-Comas A, et al Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia 2012; 55: 88–93.</mixed-citation><mixed-citation xml:lang="en">Soriguer F, Goday A, Bosch-Comas A, et al Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia 2012; 55: 88–93.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Roglic G, Unwin N, Bennett PH, et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 2005; 28 (9): 2130–5.</mixed-citation><mixed-citation xml:lang="en">Roglic G, Unwin N, Bennett PH, et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 2005; 28 (9): 2130–5.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">The Emerging Risk Factors Collaboration. Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death. N Engl J Med 2011; 364: 829–41.</mixed-citation><mixed-citation xml:lang="en">The Emerging Risk Factors Collaboration. Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death. N Engl J Med 2011; 364: 829–41.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Dedov II, Shestakova MV. The problem of quality control of diabetes care in Russia as of January 2007. Diabetes 2008; 3: 55–8. Russian (Дедов И. И., Шестакова М. В. Проблема контроля качества диабетологической помо- щи в России по данным на январь 2007 г. Сахарный диабет 2008; 3: 55–8).</mixed-citation><mixed-citation xml:lang="en">Dedov II, Shestakova MV. The problem of quality control of diabetes care in Russia as of January 2007. Diabetes 2008; 3: 55–8. Russian (Дедов И. И., Шестакова М. В. Проблема контроля качества диабетологической помо- щи в России по данным на январь 2007 г. Сахарный диабет 2008; 3: 55–8).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Suntsov YuI. Modern hypoglycemic drugs used in Russia for the treatment of type 2 diabetes. Diabetes 2012; 1: 6–9. Russian (Сунцов Ю. И. Современные сахароснижающие препараты, исполь- зуемые в России при лечении сахарного диабета 2 типа. Сахарный диабет 2012; 1: 6–9).</mixed-citation><mixed-citation xml:lang="en">Suntsov YuI. Modern hypoglycemic drugs used in Russia for the treatment of type 2 diabetes. Diabetes 2012; 1: 6–9. Russian (Сунцов Ю. И. Современные сахароснижающие препараты, исполь- зуемые в России при лечении сахарного диабета 2 типа. Сахарный диабет 2012; 1: 6–9).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Yang W, Lu J, Weng J, et al. for the China National Diabetes and Metabolic Disorders Study Group. Prevalence of Diabetes among Men and Women in China, N Engl J Med 2010; 362: 1090–101.</mixed-citation><mixed-citation xml:lang="en">Yang W, Lu J, Weng J, et al. for the China National Diabetes and Metabolic Disorders Study Group. Prevalence of Diabetes among Men and Women in China, N Engl J Med 2010; 362: 1090–101.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">National Diabetes Statistics, 2011, NIH Publication No. 11–3892 February 2011.</mixed-citation><mixed-citation xml:lang="en">National Diabetes Statistics, 2011, NIH Publication No. 11–3892 February 2011.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Dedov II. Diabetes mellitus: the development of technology in the diagnosis, treatment and prevention (plenary lecture). Diabetes 2010; 3: 6–13. Russian (Дедов И. И. Сахарный диабет: развитие техноло- гий в диагностике, лечении и профилактике (пленарная лекция). Сахарный диабет 2010; 3: 6–13).</mixed-citation><mixed-citation xml:lang="en">Dedov II. Diabetes mellitus: the development of technology in the diagnosis, treatment and prevention (plenary lecture). Diabetes 2010; 3: 6–13. Russian (Дедов И. И. Сахарный диабет: развитие техноло- гий в диагностике, лечении и профилактике (пленарная лекция). Сахарный диабет 2010; 3: 6–13).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">American Diabetes Association. Clinical practice recommendations. Diab Care 2013; 36: S1–110.</mixed-citation><mixed-citation xml:lang="en">American Diabetes Association. Clinical practice recommendations. Diab Care 2013; 36: S1–110.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Shkolnikova M, Shalnova S, Shkolnikov VM, et al. Biological mechanisms of disease and death in Moscow: rationale and design of the survey on Stress Aging and Health in Russia (SAHR). BMC Public Health 2009; 9: 293.</mixed-citation><mixed-citation xml:lang="en">Shkolnikova M, Shalnova S, Shkolnikov VM, et al. Biological mechanisms of disease and death in Moscow: rationale and design of the survey on Stress Aging and Health in Russia (SAHR). BMC Public Health 2009; 9: 293.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus Abbreviated Report of a WHO Consultation, © World Health Organization 2011.</mixed-citation><mixed-citation xml:lang="en">Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus Abbreviated Report of a WHO Consultation, © World Health Organization 2011.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Tyrovolas S, Zeimbekis A, Bountziouka V, et al Factors Associated with the Prevalence of Diabetes Mellitus Among Elderly Men and Women Living in Mediterranean Islands: The MEDIS Study Rev Diabet Stud 2009; 6: 54–63.</mixed-citation><mixed-citation xml:lang="en">Tyrovolas S, Zeimbekis A, Bountziouka V, et al Factors Associated with the Prevalence of Diabetes Mellitus Among Elderly Men and Women Living in Mediterranean Islands: The MEDIS Study Rev Diabet Stud 2009; 6: 54–63.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Panagiotakos DP, Pitsavos C, Chrysohoou C, Stefanadis C. The epidemiology of Type 2 diabetes mellitus in Greek adults: the ATTICA study. Diabet Med 2005; 22: 1581–8.</mixed-citation><mixed-citation xml:lang="en">Panagiotakos DP, Pitsavos C, Chrysohoou C, Stefanadis C. The epidemiology of Type 2 diabetes mellitus in Greek adults: the ATTICA study. Diabet Med 2005; 22: 1581–8.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Rathmann W, Haastert B, Icks A, et al. The diabetes epidemic in the elderly population in Western Europe: data from population-based studies. Gesundheitswesen 2005; 67: 110–4.</mixed-citation><mixed-citation xml:lang="en">Rathmann W, Haastert B, Icks A, et al. The diabetes epidemic in the elderly population in Western Europe: data from population-based studies. Gesundheitswesen 2005; 67: 110–4.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Bays HE, Bazata DB, Clark NG, et al. Prevalence of self-reported diagnosis of diabetes mellitus and associated risk factors in a national survey in the US population: SHIELD (Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes). BMC Public Health 2007; 7: 277 doi:10.1186/1471–2458–7–277.</mixed-citation><mixed-citation xml:lang="en">Bays HE, Bazata DB, Clark NG, et al. Prevalence of self-reported diagnosis of diabetes mellitus and associated risk factors in a national survey in the US population: SHIELD (Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes). BMC Public Health 2007; 7: 277 doi:10.1186/1471–2458–7–277.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Kanjilal S, Gregg EW, Cheng YJ, et al. Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults 1971–2002. Arch Intern Med 2006; 166: 2348–55.</mixed-citation><mixed-citation xml:lang="en">Kanjilal S, Gregg EW, Cheng YJ, et al. Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults 1971–2002. Arch Intern Med 2006; 166: 2348–55.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Hammami S, Mehri S, Hajem S, et al. Prevalence of diabetes mellitus among non institutionalized elderly in Monastir City. BMC Endocrine Disorders 2012; 12:15 http://www.biomedcentral.com/1472–6823/12/15</mixed-citation><mixed-citation xml:lang="en">Hammami S, Mehri S, Hajem S, et al. Prevalence of diabetes mellitus among non institutionalized elderly in Monastir City. BMC Endocrine Disorders 2012; 12:15 http://www.biomedcentral.com/1472–6823/12/15</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">McDonald М, Hertz RP, Unger AN, and Lustik MB. Prevalence, Awareness, and Management of Hypertension, Dyslipidemia, and Diabetes Among United States Adults Aged 65 and Older. J Gerontol A Biol Sci Med Sci 2009; 64A (2): 256–63.</mixed-citation><mixed-citation xml:lang="en">McDonald М, Hertz RP, Unger AN, and Lustik MB. Prevalence, Awareness, and Management of Hypertension, Dyslipidemia, and Diabetes Among United States Adults Aged 65 and Older. J Gerontol A Biol Sci Med Sci 2009; 64A (2): 256–63.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">THE DECODE STUDY GROUP. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003; 26 (1):61–9.</mixed-citation><mixed-citation xml:lang="en">THE DECODE STUDY GROUP. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003; 26 (1):61–9.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Agardh EE, SidorchukA, Hallqvist J, et al. Burden of type 2 diabetes attributed to lower educational levels in Sweden. Population Health Metrics 2011; 9: 60. http://www.pophealthmetrics.com/content/9/1/60.</mixed-citation><mixed-citation xml:lang="en">Agardh EE, SidorchukA, Hallqvist J, et al. Burden of type 2 diabetes attributed to lower educational levels in Sweden. Population Health Metrics 2011; 9: 60. http://www.pophealthmetrics.com/content/9/1/60.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
